Annotation Detail for ITCH

Basic Information
Top
Pathway ID | Pathway Name |
---|
200039 | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
200009 | ErbB4 signaling events |
200013 | Notch signaling pathway |
200083 | CXCR4-mediated signaling events |
200195 | TGF-beta receptor signaling |
Pathway ID | Pathway Name |
---|
P00060 | Ubiquitin proteasome pathway |
Desease Name |
---|
Autoimmune disease, syndromic multisystem |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of ITCH mRNA | decreases expression | 20406850
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of ITCH mRNA | affects expression | 17562736
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ITCH mRNA | decreases expression | 19150397 20018196
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of ITCH mRNA | increases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of ITCH mRNA | increases expression | 20106945
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of ITCH mRNA | decreases expression | 18175754
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.36 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.40 | 18445737 |
OMIM:613385 |
AUTOIMMUNE DISEASE, SYNDROMIC MULTISYSTEM |
marker/mechanism |
|
| |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
2.94 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
2.94 | 3084413 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.75 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
12.37 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
12.37 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
12.37 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.14 | 19486331 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.17 | 15894690 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.44 | 18551238 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.06 | 16285004 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.67 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.67 | 15968718 18713872 10915739 19923254 18071297 12392966 17522070 2444490 16109766 12540782 16781746 10663392 17906064 14550746 16227642 15619225 11834606 10774834 12958197 12153990 19416960 19420014 14725611 11743745 19739265 11739529 16081117 11529661 14986274 16393943 19085960 19164858 11461765 19370779 11421492 12594235 11287661 17562736 12705907 16485898 16177239 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.67 | 15131321 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.62 | 19426721 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.13 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.18 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.56 | 12639820 12168785 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.19 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.68 | 8708960 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.88 | 15720958 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.95 | 16870215 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.19 | 10903974 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.47 | 14714311 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.96 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.34 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.34 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.18 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
8.18 | 12371664 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.69 | 16610002 12969438 12587719 19784758 11587558 19460945 16611625 19014921 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.54 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.24 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.72 | 2876784 6135515 2876786 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.41 | 14737004 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.98 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.31 | 16801185 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.32 | 18551238 7678174 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.96 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.57 | 18481113 19348381 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.14 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.74 | 16049721 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.65 | 16870215 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.51 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.34 | 18760546 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.31 | 16882103 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.74 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
2.81 | 8532709 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.39 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.78 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.33 | 10982225 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.50 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.96 | 17120751 |